3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
9
Carcinoma, Intraductal, Noninfiltrating
4
Breast Carcinoma In Situ
4
Liver Neoplasms
3
Carcinoma, Hepatocellular
3
Squamous Cell Carcinoma of Head and Neck
2
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Precancerous Conditions
2
Pancreatic Neoplasms
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Neuroblastoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Erythroblastic, Acute
1
Interventions
Surveys and Questionnaires
15
Radiosurgery
14
Magnetic Resonance Imaging
11
Magnetic Resonance Spectroscopy
10
Neuropsychological Tests
8
Radiotherapy
7
Radiation
4
Blood Specimen Collection
4
Patient Reported Outcome Measures
3
sacituzumab govitecan
2
Trastuzumab
2
Surgical Procedures, Operative
2
Quality of Life
2
Physical Examination
2
Phlebotomy
2
Perfusion Magnetic Resonance Imaging
2
Lead
2
Lapatinib
2
Interviews as Topic
2
Immunotherapy
2
Drug Therapy
2
Data Collection
2
Brain Mapping
2
Bevacizumab
2
Amplified Fragment Length Polymorphism Analysis
2
Aminolevulinic Acid
2
trastuzumab deruxtecan
1
pembrolizumab
1
osimertinib
1
lorlatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Brain Neoplasms
×
Mass Spectrometry
×
Clear all
NCT04868799
2025-11-20
InnovRT1
Assistance Publique - Hôpitaux de Paris
Completed
44 enrolled